Tobradex, Augentropfensuspension

7680507660124 CH-50766 Augentropfensuspension

Associated product:

TOBRADEX susp opht fl gtt 5 ml
Tobradex, Augentropfensuspension
Tobradex, Augentropfensuspension
Tobradex, Augentropfensuspension
1 / 3
google

Article details

Package size
1 x 5
Selling units
1
Measure
ml
Galenic form
Augentropfensuspension
Galenic group
unbekannt

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
23/04/2020
Summary of Product Characteristics
Français
23/04/2020
Summary of Product Characteristics
Italien
23/04/2020
Patient information leaflet
Allemand
20/04/2020
Patient information leaflet
Français
20/04/2020
Patient information leaflet
Italien
20/04/2020

Detailed composition

Substance Quantity Type Category
(N/A)
1.0 MG Substance Wirkstoff (Principe actif)
(N/A)
3.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
0.1 MG Substance HBESI

Reimbursement information

Public price
CHF 14.85
Specialties list
Yes
Generic
No
SL addition date: 15/03/1995

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
50766
Drug name
Tobradex, Augentropfensuspension
Galenic form
AUGT
ATC Code
S01CA01
Authorization status
Z
Dispensing category
A
First authorization
15/04/1994
Authorization expiration date
31/12/9999
IT Number
11.06.1.
Domain
Human medicine
Field of application
Bakterielle Augeninfektionen

Package details

Description (FR)
TOBRADEX susp opht fl gtt 5 ml
Description (DE)
TOBRADEX Susp Opht Tropffl 5 ml
Market launch
15/04/1994
Narcotic (BTM)
No